This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
We aimed to explore the association between healthy lifestyle and higher LE8 score and apparent treatment-resistant hypertension in the general population.MethodsUsing NHANES data from 2005 to 2018, we included and analyzed information on 7,474 participants eligible for this study.
Owing to improved management, the life expectancy of patients with hemophilia has increased significantly and predisposes them to risk of cardiovascular diseases and thrombotic events. The primary outcome was to estimate the prevalence of cardiovascular riskfactors in patients with hemophilia compared to the general population.
Between 2016 and 2018, 3285 MESA participants from 6 field centers underwent comprehensive speckle-tracking echocardiography with passive leg raise maneuver, Kansas City Cardiomyopathy Questionnaire, 6-minute walk test, arterial stiffness assessment, and proteomics (including NT-proBNP [N-terminal pro-B-type natriuretic peptide]).Results:Median
We aimed to define the prevalence of systemic hypertension in MMD patients and characterize its evolution after cerebral revascularization.METHODSPatients with MMD treated with extracranial‐intracranial bypass from 2014 to 2018 were retrospectively enrolled. 6.04]), kidneydisease (OR, 18.98 [95% CI, 1.80–200.47]),
BackgroundStroke and dementia are leading causes of mortality and can be prevented through riskfactor management. Riskfactor assessment requires laboratory or physical measurements. Journal of the American Heart Association, Ahead of Print.
This can be mitigated through targeting modifiable riskfactors. Identification of those at-risk through screening tools could be facilitated by inclusion of self-reported riskfactors rather than reliance on clinical data.
Study Population includes all patients with an ischemic stroke inpatient admission in 2018 and were continuously enrolled with Medicare FFS for 1 year prior to and following their initial 2018 stroke admission. Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. female and 83.1% in study population).
Few studies, however, have investigated the risk of CTO in individuals with HU and the role of traditional cardiovascular riskfactors in this setting. Methods A cohort of 1245 individuals without chronic kidneydisease from southwest China who underwent coronary angiography between February 2018 and June 2021 were enrolled.
The objective was to develop clinical prediction models for 1-year risk of AF. Methods Using the Danish Heart Failure Registry, we conducted a nationwide registry-based cohort study of all incident HF patients diagnosed from 2008 to 2018 and without history of AF. to 5.8%), respectively, given absence of riskfactors and NYHA class I.
Salvatore Carbone, PhD: First, I’d like to point out that obesity is a major riskfactor for cardiometabolic disease. 5, 6] So, it seems that once cardiovascular disease is present, then obesity may offer some degree of protection. This benefit is less pronounced in patients with class II obesity (BMI 35 to 39.9
11 Despite the link between inflammation and cardiovascular disease has been proven by extensive research, most physicians have focused on treating high-risk patients with lipid lowering therapies including statin therapy.1,12,13 mg) to reduce the risks of heart attack, stroke, coronary revascularization, and CV death.29
CABANA Trial randomized 2204 patients with AF aged 65 years or more and those below 65 years with one or more riskfactors for stroke for catheter ablation with pulmonary vein ablation or drug therapy with rate or rhythm control. 2018 Feb 1;378(5):417-427. Catheter Ablation for Atrial Fibrillation with Heart Failure.
This study examines the association between eGFR and cardiovascular disease (CVD) risk in a representative cohort of the US adult population.MethodsA cross-sectional analysis was conducted using data from the National Health and Nutrition Examination Survey (NHANES) from 2007 to 2018.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content